Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
pharmaphorum1y
Sanofi cuts price of Lantus insulin in US by 78%
Sanofi has followed in the footsteps of its rivals in the US insulin market with a 78% price cut for its most widely-used Lantus product starting next January. It will restrict out-of-pocket costs ...
FiercePharma4d
MSF calls on Lilly, Novo and Sanofi to cut insulin pen prices to $1
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin pens to $1 per device in low- and middle-income countries (LMICs).
pharmaphorum1y
Sanofi boosts ‘connected insulin’ push with Glooko deal
Sanofi has formed another partnership to support its vision of insulin-based therapies that are connected with glucose monitoring devices and make it easier for patients to manage their blood ...